gene

FTL

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about FTL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

120Connections
0Hypotheses
2Analyses
50Outgoing
48Incoming

Summary

FTL encodes ferritin light chain, central to iron storage and antioxidant defense in the brain. Mutations cause neuroferritinopathy (NBIA), with relevance to Alzheimer's, Parkinson's, and other neurodegenerative diseases.

View on Wiki →

🧬 Gene Info
Gene SymbolFTL
Chromosome19q13.33
FunctionFe²⁺ entry: Iron enters through 3-fold hydrophilic channels
Primary Expressionhippocampus, Hippocampus
Molecular Weight20 kDa
Exons4
PathwaysLipid Metabolism, Mitophagy, Autophagy, Oxidative Stress, Ferroptosis
UniProt ID[P02792](https://www.uniprot.org/uniprot/P02792)
GeneCardsFTL
Human Protein AtlasFTL
Heteropolymer formation12 FTL + 12 FTH1 subunits (optimal ratio)
Hollow shell12-nm diameter cavity for iron storage
Ferroxidase centerCatalytic site for iron oxidation (primarily in heavy chain)
Iron nucleation sitesLight chain facilitates iron core formation
Shell stabilityProvides structural integrity for the iron core
Associated DiseasesALS, Dystonia, Leukemia, Ms, Neurodegeneration
InteractionsAPP, Rb, GPX4, SLC7A11, TFR1, PANK2
KG Connections120 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

FTL Gene

gene · 1271 words

NRF2 Oxidative Stress Pathway

mechanism · 5315 words

Ferroptosis in Alzheimer's Disease

mechanism · 4194 words

Oligodendrocyte and Myelin Dysfunction in Corticobasal Syndrome

mechanism · 3583 words

Ferroptosis in Neurodegeneration

mechanism · 3536 words

iron-calcium-glymphatic-convergence-alzheimers

general · 3516 words

Pathway Diagram

graph TD
    FTL["<b>FTL</b>"]
    FERRITINLIGHTPROTEIN["FERRITINLIGHTPROTEIN"]
    FTL -->|"component of"| FERRITINLIGHTPROTEIN
    Neurodegeneration{"Neurodegeneration"}
    FTL -->|"associated with"| Neurodegeneration
    Ms{"Ms"}
    FTL -->|"associated with"| Ms
    Parkinson{"Parkinson"}
    FTL -->|"associated with"| Parkinson
    Dystonia{"Dystonia"}
    FTL -->|"associated with"| Dystonia
    Depression{"Depression"}
    FTL -->|"inhibits"| Depression
    Alzheimer{"Alzheimer"}
    FTL -->|"inhibits"| Alzheimer
    FTL -->|"inhibits"| Ms
    Als{"Als"}
    FTL -->|"associated with"| Als
    Leukemia{"Leukemia"}
    FTL -->|"associated with"| Leukemia
    WDR45["WDR45"]
    FTL -->|"associated with"| WDR45
    COASY["COASY"]
    FTL -->|"associated with"| COASY
    ACSL4["ACSL4"]
    ACSL4 -->|"expressed in"| FTL
    TFR1["TFR1"]
    TFR1 -->|"expressed in"| FTL
    APP["APP"]
    APP -->|"inhibits"| FTL
    GPX4["GPX4"]
    GPX4 -->|"expressed in"| FTL
    SLC7A11["SLC7A11"]
    SLC7A11 -->|"expressed in"| FTL
    NRF2["NRF2"]
    NRF2 -->|"expressed in"| FTL
    FTH1["FTH1"]
    FTH1 -->|"expressed in"| FTL
    ERK["ERK"]
    ERK -->|"associated with"| FTL
    JAK["JAK"]
    JAK -->|"associated with"| FTL
    LGALS3["LGALS3"]
    LGALS3 -->|"associated with"| FTL
    PI3K["PI3K"]
    PI3K -->|"associated with"| FTL
    FGF19["FGF19"]
    FGF19 -->|"associated with"| FTL
    style FTL fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (72)

TargetRelationTypeStr
FERRITINLIGHTPROTEINcomponent_ofprotein0.90
Neurodegenerationassociated_withdisease0.65
Msassociated_withdisease0.65
Parkinsonassociated_withdisease0.65
Dystoniaassociated_withdisease0.65

Incoming (48)

SourceRelationTypeStr
ACSL4expressed_ingene0.60
TFR1expressed_ingene0.60
APPinhibitsgene0.60
GPX4expressed_ingene0.60
SLC7A11expressed_ingene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What molecular mechanisms enable functional recovery and muscle re-innervation a

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.658

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

neurodegeneration | 2026-04-07 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found